European Archives - Page 1077 of 1162 - European Medical Journal

EMJ

The causes and consequences of tumour evolution and heterogeneity

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…

EMJ

Patient-centered partnership improve access to optimal standards of cancer care in Europe

European Cancer Patient Coalition (ECPC) is the largest European cancer patients’ umbrella organisation, representing 365 patient organisations in 40…

EMJ

ECC 2015: Press programme with updates on ‘Europe of Disparities in Cancer’

At the European Cancer Congress (ECC) 2015, Mark Lawler, PhD, of Queen’s University Belfast, Belfast, UK, Richard Sullivan, MD, PhD, of King’s College…

EMJ

The discovery of new biomarkers for predicting outcomes in breast cancer

In patients with early stage breast cancer, there is a need to identify prognostic factors to determine the risk of recurrence and predictive factors to…

EMJ

First-in-human study of first-in-class fatty acid synthase inhibitor, TVB-2640

At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses a first-in…

EMJ

Exploratory analysis of frontline therapies in REVEL: A phase 3 trial of ramucirumab in NSCLC

At the European Cancer Congress (ECC) 2015, Giorgio V. Scagliotti, MD, PhD, of the University of Turin, Turin, Italy, discusses the exploratory analysis…

EMJ

ECC 2015: News briefing chaired by Prof Peter Naredi

At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a news briefing with…

EMJ

Phase 2 trial of TAK-385, an oral GnRH antagonist, in prostate cancer

At the European Cancer Congress (ECC) 2015, Neal Shore, MD, FACS, of Carolina Urologic Research Center, Myrtle Beach, SC, discusses the first interim…

EMJ

ECC 2015: Cancer healthcare inequalities between and within countries in Europe

There is a growing divide in cancer healthcare and survivorship between populations across Europe. European Cancer Patient Coalition (ECPC), the largest…

EMJ

TAILORx: Prospective phase 3 trial validating a 21-gene expression assay in breast cancer

At the European Cancer Congress (ECC) 2015, Clifford A. Hudis, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the low-risk…